Structure

Physi-Chem Properties

Molecular Weight:  494.12
Volume:  474.371
LogP:  2.664
LogD:  1.67
LogS:  -4.946
# Rotatable Bonds:  4
TPSA:  159.82
# H-Bond Aceptor:  10
# H-Bond Donor:  4
# Rings:  5
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.325
Synthetic Accessibility Score:  3.919
Fsp3:  0.269
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.24
MDCK Permeability:  1.57515678438358e-05
Pgp-inhibitor:  0.094
Pgp-substrate:  0.05
Human Intestinal Absorption (HIA):  0.464
20% Bioavailability (F20%):  0.006
30% Bioavailability (F30%):  0.991

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.1
Plasma Protein Binding (PPB):  91.00067901611328%
Volume Distribution (VD):  0.544
Pgp-substrate:  3.193326950073242%

ADMET: Metabolism

CYP1A2-inhibitor:  0.146
CYP1A2-substrate:  0.112
CYP2C19-inhibitor:  0.094
CYP2C19-substrate:  0.063
CYP2C9-inhibitor:  0.196
CYP2C9-substrate:  0.247
CYP2D6-inhibitor:  0.089
CYP2D6-substrate:  0.163
CYP3A4-inhibitor:  0.066
CYP3A4-substrate:  0.039

ADMET: Excretion

Clearance (CL):  1.463
Half-life (T1/2):  0.294

ADMET: Toxicity

hERG Blockers:  0.061
Human Hepatotoxicity (H-HT):  0.065
Drug-inuced Liver Injury (DILI):  0.981
AMES Toxicity:  0.887
Rat Oral Acute Toxicity:  0.041
Maximum Recommended Daily Dose:  0.015
Skin Sensitization:  0.1
Carcinogencity:  0.792
Eye Corrosion:  0.003
Eye Irritation:  0.089
Respiratory Toxicity:  0.022

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC186800

Natural Product ID:  NPC186800
Common Name*:   Pseudonocardone B
IUPAC Name:   (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(8-methoxy-3-methyl-7,12-dioxobenzo[a]anthracen-1-yl)oxyoxane-2-carboxylic acid
Synonyms:   Pseudonocardone B
Standard InCHIKey:  AMWRMWBDZWNIIN-TYUWDEHNSA-N
Standard InCHI:  InChI=1S/C26H22O10/c1-10-8-11-6-7-13-18(20(28)12-4-3-5-14(34-2)17(12)19(13)27)16(11)15(9-10)35-26-23(31)21(29)22(30)24(36-26)25(32)33/h3-9,21-24,26,29-31H,1-2H3,(H,32,33)/t21-,22-,23+,24-,26+/m0/s1
SMILES:  Cc1cc2ccc3c(c2c(c1)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](C(=O)O)O1)O)O)O)C(=O)c1cccc(c1C3=O)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2152475
PubChem CID:   71458437
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003415] Angucyclines

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32794 pseudonocardia sp. Species Pseudonocardiaceae Bacteria n.a. n.a. n.a. PMID[23025282]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT65 Cell Line HepG2 Homo sapiens IC50 > 100000.0 nM PMID[459989]
NPT474 Organism Plasmodium berghei Plasmodium berghei IC50 = 50000.0 nM PMID[459989]
NPT1466 Organism Escherichia coli K12 Escherichia coli K-12 MIC > 50.0 ug.mL-1 PMID[459989]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. MIC > 50.0 ug.mL-1 PMID[459989]
NPT20 Organism Candida albicans Candida albicans MIC > 50.0 ug.mL-1 PMID[459989]
NPT312 Organism Saccharomyces cerevisiae Saccharomyces cerevisiae MIC > 50.0 ug.mL-1 PMID[459989]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC186800 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9877 High Similarity NPC470667
0.9474 High Similarity NPC205721
0.9458 High Similarity NPC85368
0.9458 High Similarity NPC203751
0.9345 High Similarity NPC102053
0.9345 High Similarity NPC289876
0.9329 High Similarity NPC178281
0.9235 High Similarity NPC277710
0.9235 High Similarity NPC299149
0.9235 High Similarity NPC153578
0.9235 High Similarity NPC114257
0.9235 High Similarity NPC58538
0.9207 High Similarity NPC101116
0.9207 High Similarity NPC212099
0.9207 High Similarity NPC146837
0.9207 High Similarity NPC278329
0.9181 High Similarity NPC197357
0.9181 High Similarity NPC85316
0.9091 High Similarity NPC187934
0.9091 High Similarity NPC97637
0.9086 High Similarity NPC314672
0.908 High Similarity NPC105591
0.9075 High Similarity NPC224557
0.9075 High Similarity NPC292706
0.907 High Similarity NPC475161
0.907 High Similarity NPC477860
0.9059 High Similarity NPC68381
0.9023 High Similarity NPC87583
0.9006 High Similarity NPC475246
0.9006 High Similarity NPC76112
0.9006 High Similarity NPC170018
0.9006 High Similarity NPC66820
0.9006 High Similarity NPC92403
0.9 High Similarity NPC199357
0.8994 High Similarity NPC52598
0.8988 High Similarity NPC63470
0.8976 High Similarity NPC216752
0.8953 High Similarity NPC47191
0.8947 High Similarity NPC3718
0.8941 High Similarity NPC76128
0.8941 High Similarity NPC30432
0.8941 High Similarity NPC271385
0.8941 High Similarity NPC5029
0.8941 High Similarity NPC183441
0.8941 High Similarity NPC111536
0.8922 High Similarity NPC17432
0.8895 High Similarity NPC46958
0.8882 High Similarity NPC478021
0.8882 High Similarity NPC298778
0.8869 High Similarity NPC478020
0.8869 High Similarity NPC478022
0.8851 High Similarity NPC315221
0.8848 High Similarity NPC206641
0.8848 High Similarity NPC208651
0.8837 High Similarity NPC146803
0.883 High Similarity NPC294501
0.8824 High Similarity NPC246274
0.8824 High Similarity NPC222455
0.8807 High Similarity NPC241847
0.88 High Similarity NPC473631
0.88 High Similarity NPC313452
0.88 High Similarity NPC473717
0.88 High Similarity NPC293227
0.88 High Similarity NPC475662
0.8788 High Similarity NPC148323
0.8788 High Similarity NPC283480
0.8786 High Similarity NPC176246
0.8786 High Similarity NPC475233
0.8779 High Similarity NPC472054
0.8728 High Similarity NPC470454
0.8728 High Similarity NPC223735
0.8728 High Similarity NPC307754
0.8728 High Similarity NPC474345
0.8728 High Similarity NPC199533
0.8728 High Similarity NPC63105
0.8727 High Similarity NPC3449
0.8727 High Similarity NPC82190
0.8727 High Similarity NPC174599
0.8727 High Similarity NPC192219
0.8721 High Similarity NPC315619
0.8715 High Similarity NPC264302
0.8713 High Similarity NPC175477
0.8713 High Similarity NPC259905
0.8706 High Similarity NPC178851
0.8701 High Similarity NPC229817
0.8701 High Similarity NPC473686
0.8701 High Similarity NPC475220
0.8701 High Similarity NPC221140
0.8701 High Similarity NPC475352
0.8686 High Similarity NPC212290
0.8686 High Similarity NPC245059
0.8686 High Similarity NPC84494
0.8683 High Similarity NPC53139
0.8674 High Similarity NPC282474
0.8674 High Similarity NPC470198
0.8674 High Similarity NPC470193
0.8674 High Similarity NPC470196
0.8674 High Similarity NPC470200
0.8674 High Similarity NPC470194
0.8674 High Similarity NPC470197
0.8674 High Similarity NPC316274
0.8674 High Similarity NPC470195
0.8671 High Similarity NPC98776
0.8671 High Similarity NPC65118
0.8671 High Similarity NPC213052
0.8667 High Similarity NPC474622
0.8667 High Similarity NPC205172
0.8667 High Similarity NPC474621
0.8667 High Similarity NPC209393
0.8647 High Similarity NPC99216
0.8644 High Similarity NPC75574
0.8644 High Similarity NPC231254
0.8636 High Similarity NPC164047
0.8636 High Similarity NPC470448
0.8636 High Similarity NPC470452
0.8636 High Similarity NPC470453
0.8634 High Similarity NPC131405
0.8631 High Similarity NPC328093
0.8629 High Similarity NPC35167
0.8613 High Similarity NPC471922
0.8613 High Similarity NPC129930
0.8613 High Similarity NPC471920
0.8613 High Similarity NPC471921
0.8613 High Similarity NPC114550
0.8613 High Similarity NPC292712
0.8613 High Similarity NPC20114
0.8613 High Similarity NPC312006
0.8613 High Similarity NPC474075
0.8611 High Similarity NPC48474
0.8606 High Similarity NPC474533
0.8606 High Similarity NPC474534
0.8605 High Similarity NPC473202
0.8605 High Similarity NPC191653
0.8588 High Similarity NPC478001
0.858 High Similarity NPC72783
0.8571 High Similarity NPC232818
0.8571 High Similarity NPC198893
0.8571 High Similarity NPC61904
0.8571 High Similarity NPC144097
0.8571 High Similarity NPC314489
0.8564 High Similarity NPC314459
0.8564 High Similarity NPC470199
0.8563 High Similarity NPC229051
0.8563 High Similarity NPC470336
0.8563 High Similarity NPC470438
0.8563 High Similarity NPC154986
0.8563 High Similarity NPC470335
0.8555 High Similarity NPC313304
0.8555 High Similarity NPC280385
0.8555 High Similarity NPC76047
0.8555 High Similarity NPC469344
0.8547 High Similarity NPC65489
0.8547 High Similarity NPC469521
0.8538 High Similarity NPC129264
0.8538 High Similarity NPC19240
0.8538 High Similarity NPC139060
0.8538 High Similarity NPC280923
0.8538 High Similarity NPC470735
0.8538 High Similarity NPC205824
0.8538 High Similarity NPC329647
0.8538 High Similarity NPC85751
0.8531 High Similarity NPC208069
0.8529 High Similarity NPC326278
0.8523 High Similarity NPC217387
0.8523 High Similarity NPC477895
0.8523 High Similarity NPC217520
0.8523 High Similarity NPC293626
0.8523 High Similarity NPC113836
0.8523 High Similarity NPC258044
0.8523 High Similarity NPC477682
0.8523 High Similarity NPC139571
0.8523 High Similarity NPC253521
0.8523 High Similarity NPC196127
0.8523 High Similarity NPC477683
0.8523 High Similarity NPC470334
0.8523 High Similarity NPC267680
0.8523 High Similarity NPC37668
0.8514 High Similarity NPC34267
0.8514 High Similarity NPC81042
0.8514 High Similarity NPC214621
0.8514 High Similarity NPC193377
0.8514 High Similarity NPC70862
0.8514 High Similarity NPC223426
0.8512 High Similarity NPC177742
0.8506 High Similarity NPC478002
0.8506 High Similarity NPC217822
0.8506 High Similarity NPC473113
0.8506 High Similarity NPC221288
0.8506 High Similarity NPC101399
0.8506 High Similarity NPC11847
0.8497 Intermediate Similarity NPC137460
0.8488 Intermediate Similarity NPC477835
0.8483 Intermediate Similarity NPC36138
0.8483 Intermediate Similarity NPC97119
0.8483 Intermediate Similarity NPC135831
0.8483 Intermediate Similarity NPC476203
0.8483 Intermediate Similarity NPC297503
0.848 Intermediate Similarity NPC66087
0.848 Intermediate Similarity NPC179198
0.848 Intermediate Similarity NPC278419

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC186800 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.908 High Similarity NPD7879 Clinical (unspecified phase)
0.9006 High Similarity NPD8312 Approved
0.9006 High Similarity NPD8313 Approved
0.8587 High Similarity NPD7435 Discontinued
0.8424 Intermediate Similarity NPD6776 Approved
0.8424 Intermediate Similarity NPD6778 Approved
0.8424 Intermediate Similarity NPD6782 Approved
0.8424 Intermediate Similarity NPD6779 Approved
0.8424 Intermediate Similarity NPD6780 Approved
0.8424 Intermediate Similarity NPD6781 Approved
0.8424 Intermediate Similarity NPD6777 Approved
0.8391 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8352 Intermediate Similarity NPD6559 Discontinued
0.8333 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8316 Intermediate Similarity NPD7874 Approved
0.8316 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.8313 Intermediate Similarity NPD3226 Approved
0.8256 Intermediate Similarity NPD6959 Discontinued
0.8245 Intermediate Similarity NPD7870 Phase 2
0.8245 Intermediate Similarity NPD7871 Phase 2
0.8229 Intermediate Similarity NPD3751 Discontinued
0.8225 Intermediate Similarity NPD8455 Phase 2
0.8225 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8208 Intermediate Similarity NPD3787 Discontinued
0.8202 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8192 Intermediate Similarity NPD6797 Phase 2
0.8191 Intermediate Similarity NPD7696 Phase 3
0.8191 Intermediate Similarity NPD7697 Approved
0.8191 Intermediate Similarity NPD7698 Approved
0.8187 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD7075 Discontinued
0.8182 Intermediate Similarity NPD5844 Phase 1
0.8168 Intermediate Similarity NPD8151 Discontinued
0.8152 Intermediate Similarity NPD6535 Approved
0.8152 Intermediate Similarity NPD6534 Approved
0.8148 Intermediate Similarity NPD8319 Approved
0.8148 Intermediate Similarity NPD8320 Phase 1
0.8146 Intermediate Similarity NPD7251 Discontinued
0.8118 Intermediate Similarity NPD7819 Suspended
0.8115 Intermediate Similarity NPD7701 Phase 2
0.8103 Intermediate Similarity NPD6232 Discontinued
0.8101 Intermediate Similarity NPD7808 Phase 3
0.8086 Intermediate Similarity NPD2346 Discontinued
0.807 Intermediate Similarity NPD5402 Approved
0.8068 Intermediate Similarity NPD7473 Discontinued
0.8059 Intermediate Similarity NPD6801 Discontinued
0.8034 Intermediate Similarity NPD7074 Phase 3
0.8022 Intermediate Similarity NPD8150 Discontinued
0.8021 Intermediate Similarity NPD7699 Phase 2
0.8021 Intermediate Similarity NPD7700 Phase 2
0.8011 Intermediate Similarity NPD6166 Phase 2
0.8011 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8011 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.799 Intermediate Similarity NPD7801 Approved
0.799 Intermediate Similarity NPD7783 Phase 2
0.799 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.799 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7988 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7978 Intermediate Similarity NPD7054 Approved
0.7941 Intermediate Similarity NPD6599 Discontinued
0.7933 Intermediate Similarity NPD7472 Approved
0.7921 Intermediate Similarity NPD3818 Discontinued
0.791 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7903 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7903 Intermediate Similarity NPD6213 Phase 3
0.7903 Intermediate Similarity NPD6212 Phase 3
0.7895 Intermediate Similarity NPD7411 Suspended
0.7889 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7882 Intermediate Similarity NPD7458 Discontinued
0.787 Intermediate Similarity NPD5403 Approved
0.7861 Intermediate Similarity NPD3817 Phase 2
0.7857 Intermediate Similarity NPD5401 Approved
0.7853 Intermediate Similarity NPD6823 Phase 2
0.7836 Intermediate Similarity NPD4380 Phase 2
0.7816 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7798 Intermediate Similarity NPD6799 Approved
0.7751 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7725 Intermediate Similarity NPD4628 Phase 3
0.7701 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7676 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7665 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7657 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7654 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7634 Intermediate Similarity NPD8434 Phase 2
0.7624 Intermediate Similarity NPD7177 Discontinued
0.7614 Intermediate Similarity NPD7768 Phase 2
0.7584 Intermediate Similarity NPD5494 Approved
0.7571 Intermediate Similarity NPD3749 Approved
0.7551 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.7544 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7543 Intermediate Similarity NPD1934 Approved
0.7542 Intermediate Similarity NPD7199 Phase 2
0.7527 Intermediate Similarity NPD7228 Approved
0.7515 Intermediate Similarity NPD7003 Approved
0.7514 Intermediate Similarity NPD3882 Suspended
0.7513 Intermediate Similarity NPD8285 Discontinued
0.7485 Intermediate Similarity NPD2313 Discontinued
0.7443 Intermediate Similarity NPD37 Approved
0.7442 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7442 Intermediate Similarity NPD2534 Approved
0.7442 Intermediate Similarity NPD2533 Approved
0.7442 Intermediate Similarity NPD2532 Approved
0.7425 Intermediate Similarity NPD2799 Discontinued
0.7416 Intermediate Similarity NPD4965 Approved
0.7416 Intermediate Similarity NPD4967 Phase 2
0.7416 Intermediate Similarity NPD4966 Approved
0.7401 Intermediate Similarity NPD1465 Phase 2
0.7399 Intermediate Similarity NPD6273 Approved
0.7384 Intermediate Similarity NPD7390 Discontinued
0.7381 Intermediate Similarity NPD5406 Approved
0.7381 Intermediate Similarity NPD5405 Approved
0.7381 Intermediate Similarity NPD5404 Approved
0.7381 Intermediate Similarity NPD5408 Approved
0.7378 Intermediate Similarity NPD6798 Discontinued
0.7366 Intermediate Similarity NPD7240 Approved
0.7366 Intermediate Similarity NPD7685 Pre-registration
0.7356 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD6674 Discontinued
0.7337 Intermediate Similarity NPD7799 Discontinued
0.7337 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD6234 Discontinued
0.7333 Intermediate Similarity NPD919 Approved
0.732 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD2801 Approved
0.7294 Intermediate Similarity NPD1549 Phase 2
0.7286 Intermediate Similarity NPD8058 Clinical (unspecified phase)
0.7286 Intermediate Similarity NPD8059 Phase 3
0.7283 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD2796 Approved
0.7278 Intermediate Similarity NPD2935 Discontinued
0.7268 Intermediate Similarity NPD3926 Phase 2
0.7262 Intermediate Similarity NPD7097 Phase 1
0.7246 Intermediate Similarity NPD1933 Approved
0.7243 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7238 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7235 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7235 Intermediate Similarity NPD5763 Approved
0.7235 Intermediate Similarity NPD1471 Phase 3
0.7235 Intermediate Similarity NPD5762 Approved
0.7235 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7229 Intermediate Similarity NPD6233 Phase 2
0.7225 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7209 Intermediate Similarity NPD3750 Approved
0.72 Intermediate Similarity NPD1512 Approved
0.7186 Intermediate Similarity NPD4060 Phase 1
0.7176 Intermediate Similarity NPD1551 Phase 2
0.7168 Intermediate Similarity NPD6190 Approved
0.7159 Intermediate Similarity NPD920 Approved
0.7158 Intermediate Similarity NPD8127 Discontinued
0.7158 Intermediate Similarity NPD1247 Approved
0.7152 Intermediate Similarity NPD6832 Phase 2
0.7143 Intermediate Similarity NPD6355 Discontinued
0.7143 Intermediate Similarity NPD7446 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD2344 Approved
0.7134 Intermediate Similarity NPD2798 Approved
0.712 Intermediate Similarity NPD7229 Phase 3
0.7118 Intermediate Similarity NPD7033 Discontinued
0.7118 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD3748 Approved
0.7114 Intermediate Similarity NPD7999 Approved
0.7093 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7087 Intermediate Similarity NPD7930 Approved
0.7086 Intermediate Similarity NPD1511 Approved
0.7079 Intermediate Similarity NPD7584 Approved
0.7076 Intermediate Similarity NPD2438 Suspended
0.7073 Intermediate Similarity NPD1470 Approved
0.7066 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7056 Intermediate Similarity NPD6844 Discontinued
0.7052 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7045 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD447 Suspended
0.7041 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD5953 Discontinued
0.7035 Intermediate Similarity NPD7266 Discontinued
0.7027 Intermediate Similarity NPD5710 Approved
0.7027 Intermediate Similarity NPD5711 Approved
0.7018 Intermediate Similarity NPD1510 Phase 2
0.7011 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD1607 Approved
0.6994 Remote Similarity NPD2897 Discontinued
0.6994 Remote Similarity NPD1608 Approved
0.6982 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6971 Remote Similarity NPD2309 Approved
0.6954 Remote Similarity NPD1243 Approved
0.6952 Remote Similarity NPD7784 Clinical (unspecified phase)
0.6932 Remote Similarity NPD643 Clinical (unspecified phase)
0.6927 Remote Similarity NPD1653 Approved
0.6919 Remote Similarity NPD4308 Phase 3
0.6912 Remote Similarity NPD7583 Approved
0.6911 Remote Similarity NPD8368 Discontinued
0.6911 Remote Similarity NPD6765 Approved
0.6911 Remote Similarity NPD6764 Approved
0.691 Remote Similarity NPD5049 Phase 3
0.6909 Remote Similarity NPD1283 Approved
0.6905 Remote Similarity NPD7095 Approved
0.6887 Remote Similarity NPD8366 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data